DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/frmprp/the_market_for) has announced the addition of the "The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends" report to their offering.
The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.
Forces Driving the Stem Cell Biobanking Market Stem cell research and experimentation is largely driven by the unique ability of stem cells to divide and replicate repeatedly. In addition, their unspecialized nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.
Therefore, the possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington's disease, Parkinson's disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.
However, to have stem cells easily accessible for research purposes and clinical applications requires them to be preserved in stable, temperature controlled conditions. For this reason, a substantial market has evolved for the biobanking of tissues containing stem cell populations and the storage of stem cells themselves.
This global strategic report is produced for:
- Executives of Industrial-Scale Biobanks
- Management of Stem Cell Product Companies
- Management of Stem Cell Therapy Companies
- Biobanking Industry Investors
It is designed to increase your efficiency and effectiveness in:
- Effectively pricing stem cell biobanking services
- Increasing revenue from stem cell biobanking services
- Identifying new or adjunct stem cell biobanking services to offer
- Identifying current market leaders within the stem cell biobanking market
- Characterizing the competitive environment for the stem cell biobanking market
- Identifying threats and opportunities within the stem cell biobanking market
- Acquiring greater market within the stem cell biobanking market
- Making intelligent investment decisions within the stem cell biobanking market
The following are stages during which stem cells can be derived:
- Embryonic stem cells, derived from blastocysts
- Fetal stem cells, obtained from fetuses
- Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue
- Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells
- Induced pluripotent stem cells, reprogrammed from adult cells
- Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
Key Topics Covered:
1. Introduction
2. Scope
3. Goals Of Report
4. Methodology
5. Applications For Stored Stem Cells (End-Uses)
6. Market Size Determinations For The Stem Cell Biobanking Market
7. Basic Variables For The Stem Cell Biobanking Market
8. Industry Leaders
9. Breakdown Of Market Share, By Customer
10. Market Characterization
Appendices
Companies Mentioned
- BioStorage Technologies
- EPL Archives
- Fisher BioServices
- Precision Bioservices
For more information visit http://www.researchandmarkets.com/research/frmprp/the_market_for
